đź“‹ FDA Reference

Cook Clect Vena Cava Filter Gunther Tulip Vena Cava Filter Retrieval Set

William Cook Europe ApS

Product: Cook Celect — all models and sizes

Contact a rep Compare similar devices

Summary: The Cook Clect Vena Cava Filter is a medical device used to prevent pulmonary embolism by capturing blood clots in the inferior vena cava. It is primarily used by interventional radiologists and vascular surgeons.

FDA Clearance Information

Pathway ? 510(k)
Number ? K073374 ↗
Decision Date ? March 7, 2008
Product Code ? DTK Filter, Intravascular, Cardiovascular
Device Class ? Class 2
Evidence ? 10 studies

The Cook Clect Vena Cava Filter was cleared through the FDA 510(k) pathway on March 7, 2008. Manufactured by William Cook Europe Aps, it is classified as a Class 2 device under product code DTK.

What It Is

The Cook Clect Vena Cava Filter is a retrievable filter designed for placement in the inferior vena cava (IVC) to capture emboli and prevent them from reaching the pulmonary arteries. It consists of a metal framework that expands to fit the IVC, allowing blood flow while trapping clots. The filter can be retrieved when it is no longer needed, providing flexibility in patient management.

FDA-Cleared Indications

  • Prevention of recurrent pulmonary embolism in patients with contraindications to anticoagulation therapy.
  • Prevention of recurrent pulmonary embolism in patients who experience recurrent embolism despite adequate anticoagulation.

Clinical Applications

  • Placement in the inferior vena cava to prevent recurrent pulmonary embolism.
  • Use in patients who cannot receive anticoagulant medication because of a contraindication.
  • Use in patients with recurrent pulmonary embolism despite adequate anticoagulation.
  • Percutaneous IVC filter placement using an imaging-guided delivery system.
  • Percutaneous retrieval when the filter is no longer clinically needed, when retrieval is feasible and appropriate.

Reported off-label uses

  • Temporary pulmonary embolism protection in selected high-risk patients who do not meet the labeled indications, such as some trauma or perioperative patients.
  • Use as prophylaxis against pulmonary embolism in selected patients without documented recurrent embolism or a contraindication to anticoagulation.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • The IVC should be evaluated with appropriate imaging before placement, including assessment of diameter, thrombus, renal veins and other relevant anatomy.
  • The device is available in size configurations intended for different IVC diameters; clinicians should confirm the current instructions for use and compatible delivery system before the procedure.
  • Placement and retrieval are typically performed through venous access, commonly the internal jugular or common femoral vein, with fluoroscopic or other appropriate imaging guidance.
  • Retrieval may become more difficult as dwell time increases or if the filter tilts, becomes embedded, penetrates the IVC wall or develops substantial thrombus. Retrieval should be considered when protection is no longer needed and the benefits outweigh the risks.
  • MRI safety and conditions depend on the specific filter model and current labeling. The device and its instructions for use should be verified before MRI; MRI conditional status should not be assumed from the device category alone.

Procedures that use this device

Linked Studies (10)

PubMed • 2022

Case report: Endoluminal removal of a retrievable conical inferior vena cava filter with a ruptured retraction hook attached to the wall.

Frontiers in surgery

Case Report View Source →
PubMed • 2016

Factors affecting Cook Gunther Tulip and Cook Celect inferior vena cava filter retrieval success.

Journal of vascular surgery. Venous and lymphatic disorders

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2014

Safety and efficacy of the Gunther Tulip retrievable vena cava filter: midterm outcomes.

Cardiovascular and interventional radiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2013

Successful removal of a Gunther tulip vena cava filter with wall-embedded hook and migration during a retrieval attempt.

Acta radiologica short reports

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2013

Retrieval of gunther tulip vena cava filter with thrombosed hook and a leg incorporated into the vena cava wall.

Annals of vascular diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2011

Endovascular repair of a perforation of the vena caval wall caused by the retrieval of a Gunther Tulip filter after long-term implantation.

Cardiovascular and interventional radiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2008

Form and function of vena cava filters: how do optional filters measure up?

Vascular

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2007

Evaluation of retrievability of the Gunther tulip vena cava filter.

Cardiovascular and interventional radiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2005

New optional IVC filter for percutaneous retrieval--in vitro evaluation of embolus capturing efficiency.

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin

RCT|prospective|retrospective|case Series|other View Source →
ClinicalTrials.gov

Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study

View Source →

Frequently Asked Questions

What is the Cook Clect Vena Cava Filter used for?

It is used to prevent pulmonary embolism by capturing blood clots in the inferior vena cava.

What specialties typically use this device?

Interventional radiologists and vascular surgeons typically use this device.

What are the FDA-cleared indications?

It is indicated for preventing recurrent pulmonary embolism in patients who cannot use anticoagulation therapy or have recurrent embolism despite it.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you